<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Synaptic Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Synaptic Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Synaptic Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Synaptic Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-3563</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30800064</article-id>
<article-id pub-id-type="pmc">6375879</article-id>
<article-id pub-id-type="doi">10.3389/fnsyn.2019.00002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dysregulated Ca<sup>2+</sup>-Permeable AMPA Receptor Signaling in Neural Progenitors Modeling Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Danesi</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/680516/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keinänen</surname>
<given-names>Kari</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/396382/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Castrén</surname>
<given-names>Maija L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/112708/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Physiology, Faculty of Medicine, University of Helsinki</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
<aff id="aff2"><sup>2</sup><institution>Research Program in Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Karri P. Lamsa, University of Szeged, Hungary</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Zhengping Jia, Hospital for Sick Children, Canada; Silvia Bassani, Institute of Neuroscience (IN), Italy; Jason D. Shepherd, University of Utah, United States</p>
</fn>
<corresp id="c001">*Correspondence: Maija L. Castrén <email>maija.castren@helsinki.fi</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>11</volume>
<elocation-id>2</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Danesi, Keinänen and Castrén.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Danesi, Keinänen and Castrén</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Fragile X syndrome (FXS) is a neurodevelopmental disorder that represents a common cause of intellectual disability and is a variant of autism spectrum disorder (ASD). Studies that have searched for similarities in syndromic and non-syndromic forms of ASD have paid special attention to alterations of maturation and function of glutamatergic synapses. Copy number variations (CNVs) in the loci containing genes encoding alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors (AMPARs) subunits are associated with ASD in genetic studies. In FXS, dysregulated AMPAR subunit expression and trafficking affect neural progenitor differentiation and synapse formation and neuronal plasticity in the mature brain. Decreased expression of GluA2, the AMPAR subunit that critically controls Ca<sup>2+</sup>-permeability, and a concomitant increase in Ca<sup>2+</sup>-permeable AMPARs (CP-AMPARs) in human and mouse FXS neural progenitors parallels changes in expression of GluA2-targeting microRNAs (miRNAs). Thus, posttranscriptional regulation of GluA2 by miRNAs and subsequent alterations in calcium signaling may contribute to abnormal synaptic function in FXS and, by implication, in some forms of ASD.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>AMPA</kwd>
<kwd>GluA2</kwd>
<kwd>fragile X syndrome</kwd>
<kwd>miRNA</kwd>
<kwd>miR-181</kwd>
<kwd>neural progenitor</kwd>
<kwd>plasticity</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Academy of Finland<named-content content-type="fundref-id">10.13039/501100002341</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="115"></ref-count>
<page-count count="8"></page-count>
<word-count count="6630"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental disorders that are characterized by defective social interaction, impairment in verbal and nonverbal communication, repetitive and restricted behavior, and sensory abnormalities (American Psychiatric Association, <xref ref-type="bibr" rid="B3">2013</xref>). Many autistic individuals display a variety of additional neuropsychiatric features (Simonoff et al., <xref ref-type="bibr" rid="B91">2008</xref>), an abnormal intellectual profile (Fombonne, <xref ref-type="bibr" rid="B29">2003</xref>; Rydzewska et al., <xref ref-type="bibr" rid="B83">2018</xref>), and epilepsy (Besag, <xref ref-type="bibr" rid="B9">2017</xref>), indicating a high rate of co-morbidity among the neurodevelopmental defects (DiCicco-Bloom et al., <xref ref-type="bibr" rid="B24">2006</xref>). ASD has a strong genetic component and genetic studies have implicated hundreds of genes associated with increased risk of ASD (Persico and Napolioni, <xref ref-type="bibr" rid="B77">2013</xref>). Extreme locus heterogeneity in ASD suggests that an interplay of common and rare genetic variations contribute to the ASD phenotype (O’Roak et al., <xref ref-type="bibr" rid="B72">2012</xref>). These findings have led to the identification of candidate pathways and functional changes involved in the pathophysiology of ASD (Pinto et al., <xref ref-type="bibr" rid="B78">2010</xref>). Many of the ASD risk genes are particularly important during brain development (Pardo and Eberhart, <xref ref-type="bibr" rid="B74">2007</xref>). Features of autism associate with distinct rare monogenic neurodevelopmental syndromes, including fragile X syndrome (FXS), tuberosis sclerosis, and Rett syndrome (Lintas et al., <xref ref-type="bibr" rid="B61">2012</xref>). Syndromic single-gene disorders provide an excellent possibility to investigate the molecular and cellular mechanisms that increase the risk of autism. In this context, maturation and function of glutamatergic synapses have received attention (Uzunova et al., <xref ref-type="bibr" rid="B102">2014</xref>; Fung and Hardan, <xref ref-type="bibr" rid="B31">2015</xref>).</p>
<p>Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors (AMPARs) are the main mediators of excitatory transmission and synaptic strength in neuronal plasticity. A decreased density of AMPARs has been found in the post-mortem cerebellum of individuals with autism (Purcell et al., <xref ref-type="bibr" rid="B79">2001</xref>). Furthermore, AMPAR modulation can normalize abnormal excitatory transmission and social impairments in animal models of ASD (Kim et al., <xref ref-type="bibr" rid="B49">2019</xref>). AMPARs are formed by four subunits, GluA1–4. The predominantly expressed edited GluA2 subunit makes the receptor impermeable to divalent cations, whereas the receptors lacking GluA2 are permeable to Ca<sup>2+</sup> and show strong inward rectification that is caused by intracellular polyamine block (Donevan and Rogawski, <xref ref-type="bibr" rid="B26">1995</xref>; Bowie et al., <xref ref-type="bibr" rid="B12">1998</xref>; Kumar et al., <xref ref-type="bibr" rid="B51">2002</xref>). A genetic deletion that includes the <italic>GRIA2</italic> gene encoding GluA2 is associated with autism (Ramanathan et al., <xref ref-type="bibr" rid="B80">2004</xref>) and mutations of RAB39B that cause intellectual disability comorbid with autism lead to impaired transport of GluA2 to synapses and subsequent shift of AMPAR to higher calcium permeability (Mignogna et al., <xref ref-type="bibr" rid="B70">2015</xref>).</p>
<p>FXS is the most common inherited intellectual disability syndrome (Santoro et al., <xref ref-type="bibr" rid="B86">2012</xref>) and is considered as the most common single-gene condition associated with autism (Hernandez et al., <xref ref-type="bibr" rid="B40">2009</xref>). The FXS phenotype includes hyperactivity, defects in sensory integration, communication difficulties, poor motor coordination, social anxiety, and restricted repetitive and stereotyped patterns of behavior (Hagerman et al., <xref ref-type="bibr" rid="B36">2010</xref>). Epilepsy in 13%–44% of FXS cases shows an age-related appearance (Kluger et al., <xref ref-type="bibr" rid="B50">1996</xref>; Berry-Kravis, <xref ref-type="bibr" rid="B7">2002</xref>; Louhivuori et al., <xref ref-type="bibr" rid="B65">2009</xref>). FXS accounts for 5%–7% of all ASD cases (Hagerman et al., <xref ref-type="bibr" rid="B36">2010</xref>). Depending on the diagnostic criteria used, 30%–54% of males and 16%–20% of females with FXS fulfil the standardized criteria of autism (Brown et al., <xref ref-type="bibr" rid="B15">1986</xref>; Hernandez et al., <xref ref-type="bibr" rid="B40">2009</xref>; Kaufmann et al., <xref ref-type="bibr" rid="B48">2017</xref>). Impaired glutamate receptor-mediated plasticity is implicated in FXS and an imbalance of excitation and inhibition at the neuronal circuit level has been found in the mouse model of FXS [<italic>Fmr1</italic> knockout (KO) mice; Bear et al., <xref ref-type="bibr" rid="B6">2004</xref>; Bassel and Warren, <xref ref-type="bibr" rid="B5">2008</xref>; Gibson et al., <xref ref-type="bibr" rid="B33">2008</xref>; Harlow et al., <xref ref-type="bibr" rid="B38">2010</xref>; Gonçalves et al., <xref ref-type="bibr" rid="B34">2013</xref>; Zhang et al., <xref ref-type="bibr" rid="B112">2014</xref>]. This review summarizes AMPAR alterations observed in FXS used as a model for studies of autism symptomatology.</p>
</sec>
<sec id="s2">
<title>Altered Synapse Function in FXS</title>
<p>FXS is caused by the absence of the FMR1 protein (FMRP), which results from promoter methylation and transcriptional silencing of the <italic>FMR1</italic> gene with CGG triplet repeat expansion (&gt;200 repeats) in the 5′ untranslated part of the gene (Verkerk et al., <xref ref-type="bibr" rid="B104">1991</xref>). FMRP is an RNA-binding protein that is involved in the regulation of transport and translation of specific mRNAs. It is estimated that roughly 4% of brain mRNAs interacts with FMRP (Brown et al., <xref ref-type="bibr" rid="B16">2001</xref>) and many of the FMRP target mRNAs are associated with ASD (Darnell et al., <xref ref-type="bibr" rid="B21">2011</xref>). In addition to mRNA interactions, FMRP associates with microRNAs (miRNAs) and components of the miRNA pathway, including Dicer and Argonaute proteins (Siew et al., <xref ref-type="bibr" rid="B90">2013</xref>). In addition, direct protein-protein interactions between FMRP and ion channels have been found (Brown et al., <xref ref-type="bibr" rid="B14">2010</xref>; Ferron, <xref ref-type="bibr" rid="B28">2016</xref>). Several presynaptic and postsynaptic proteins, including proteins involved in the regulation of membrane excitability, ionic homeostasis, and neurotransmitter release, are abnormally regulated in the brain of <italic>Fmr1</italic> KO mice, which recapitulate the main human FXS phenotype (Jin and Warren, <xref ref-type="bibr" rid="B47">2000</xref>).</p>
<p>Exaggerated type I metabotropic glutamate receptor (mGluR)-mediated synaptic translation enhances long-term synaptic depression (LTD) in the absence of FMRP (Huber et al., <xref ref-type="bibr" rid="B43">2002</xref>; Bear et al., <xref ref-type="bibr" rid="B6">2004</xref>). Long-term potentiation (LTP) is also affected in <italic>Fmr1</italic> KO mice (Li et al., <xref ref-type="bibr" rid="B58">2002</xref>; Zhao et al., <xref ref-type="bibr" rid="B113">2005</xref>; Desai et al., <xref ref-type="bibr" rid="B23">2006</xref>; Lauterborn et al., <xref ref-type="bibr" rid="B55">2007</xref>; Wang et al., <xref ref-type="bibr" rid="B103">2010</xref>; Xu et al., <xref ref-type="bibr" rid="B110">2012</xref>). Differences in the threshold for the induction of LTP in the absence of FMRP implicate altered neuronal and particularly dendritic excitability to neuronal plasticity changes (Meredith et al., <xref ref-type="bibr" rid="B69">2007</xref>; Meredith and Mansvelder, <xref ref-type="bibr" rid="B67">2010</xref>). Compromised spike-timing-dependent LTP in the prefrontal cortex of <italic>Fmr1</italic> KO mice can be restored by increasing neuronal activity and rearing these mice in an enriched environment restores synaptic plasticity (Meredith et al., <xref ref-type="bibr" rid="B69">2007</xref>). There is evidence that the absence of FMRP leads to dysregulation of several ion channels, including L-type voltage-gated calcium channels (Meredith et al., <xref ref-type="bibr" rid="B69">2007</xref>; Castagnola et al., <xref ref-type="bibr" rid="B18">2018</xref>; Danesi et al., <xref ref-type="bibr" rid="B20">2018</xref>) and potassium (K+) channels (Brown et al., <xref ref-type="bibr" rid="B14">2010</xref>; Deng et al., <xref ref-type="bibr" rid="B22">2013</xref>), which may contribute to defects in cellular excitability and neuronal plasticity in FXS.</p>
</sec>
<sec id="s3">
<title>Dysregulated Localization of AMPAR in FXS</title>
<p>Ionotropic glutamate receptors are expressed already before synaptogenesis and have roles in neuronal development in addition to their function as mediators of synaptic transmission and plasticity in mature neurons (Schlett, <xref ref-type="bibr" rid="B87">2006</xref>). Alterations of AMPARs are consistent with defective functional maturation and neuronal plasticity in the FXS mouse brain. In the neonatal brain, a large fraction of synapses are functionally silent due to the absence of AMPARs and tonic Mg<sup>2+</sup> block of N-Methyl-D-aspartate receptors (NMDARs; Malenka and Nicoll, <xref ref-type="bibr" rid="B66">1997</xref>; Hanse et al., <xref ref-type="bibr" rid="B37">2013</xref>). Upon later development, insertion of AMPARs to synaptic membranes unsilences most of the silent synapses (Wu et al., <xref ref-type="bibr" rid="B109">1996</xref>). Silent synapses are increased in the <italic>Fmr1</italic> KO mouse brain during the first postnatal weeks (Harlow et al., <xref ref-type="bibr" rid="B38">2010</xref>). The AMPA/NMDA amplitude ratio of evoked synaptic responses appears to be the lowest before closure of the critical period, reflecting delayed synapse stabilization which involves delayed refinement of cortical excitatory circuits in the FXS mouse brain (Harlow et al., <xref ref-type="bibr" rid="B38">2010</xref>).</p>
<p>FMRP promotes neuronal maturation by membrane delivery of GluA1 without affecting total GluA1 protein expression (Darnell et al., <xref ref-type="bibr" rid="B21">2011</xref>; Guo et al., <xref ref-type="bibr" rid="B35">2015</xref>). In contrast, the autosomal paralog of FMRP, FXR2P, increases GluA1 expression <italic>via</italic> direct interaction with <italic>GluA1</italic> mRNA and affects mRNA stability (Guo et al., <xref ref-type="bibr" rid="B35">2015</xref>). In the <italic>Fmr1</italic> KO mouse brain, internalization of surface GluA1 is abnormal in the prefrontal cortex and amygdala, which represent brain regions implicated in the neuropathology of autism (Suvrathan et al., <xref ref-type="bibr" rid="B96">2010</xref>; Wang et al., <xref ref-type="bibr" rid="B103">2010</xref>). Augmented LTD leads to increased AMPAR internalization in the hippocampus and cerebellum of the <italic>Fmr1</italic> KO mouse (Huber et al., <xref ref-type="bibr" rid="B43">2002</xref>; Bear et al., <xref ref-type="bibr" rid="B6">2004</xref>; Nakamoto et al., <xref ref-type="bibr" rid="B71">2007</xref>). Retinoic acid-dependent synaptic scaling <italic>via</italic> dendritic translation of GluA1 subunit of AMPARs is also disturbed (Soden and Chen, <xref ref-type="bibr" rid="B92">2010</xref>). Expression of GluA1 and GluA2 mRNAs is reduced in the prefrontal cortex of the <italic>Fmr1</italic> KO mouse when compared to wild-type controls (Achuta et al., <xref ref-type="bibr" rid="B2">2018</xref>), but it is not known whether the changes of AMPAR expression observed in the FXS mouse brain correlate with changes in human brain.</p>
</sec>
<sec id="s4">
<title>Ion Channel Function of AMPAR in FXS</title>
<p>Independent of their role in synaptic transmission, Ca<sup>2+</sup>-permeable AMPARs (CP-AMPARs) have developmental functions that emerged already early in evolution (Hirai et al., <xref ref-type="bibr" rid="B41">2017</xref>). Expression of GluA2 is low in the early developmental stages, suggesting that Ca<sup>2+</sup> influx through CP-AMPARs contributes to the regulation of neuronal and glial development (Kumar et al., <xref ref-type="bibr" rid="B51">2002</xref>; Zonouzi et al., <xref ref-type="bibr" rid="B114">2011</xref>; Lalanne et al., <xref ref-type="bibr" rid="B54">2016</xref>; Szczurowska et al., <xref ref-type="bibr" rid="B97">2016</xref>). In normal neuronal development, the CP-AMPARs expressed during early development are subsequently replaced by GluA2-containing, calcium-impermeable receptors, which dominate in the mature nervous system (Kumar et al., <xref ref-type="bibr" rid="B51">2002</xref>). Interestingly, in some disorders of developmental origin, this subunit switch is delayed leading to an increased GluA1/GluA2 ratio or calcium permeability (Talos et al., <xref ref-type="bibr" rid="B98">2006</xref>; Ruffolo et al., <xref ref-type="bibr" rid="B82">2016</xref>), consistent with recent findings in studies performed on human FXS neural progenitors (Achuta et al., <xref ref-type="bibr" rid="B2">2018</xref>). AMPARs are expressed in the embryonic proliferative ventricular and subventricular zones, where the neural progenitors reside (Lidow and Rakic, <xref ref-type="bibr" rid="B60">1995</xref>; LoTurco et al., <xref ref-type="bibr" rid="B64">1995</xref>). Neural progenitors express both AMPA and NMDA receptors in a progenitor type- and developmental stage-dependent manner, and these receptors mediate important regulatory signals during progenitor differentiation (LoTurco et al., <xref ref-type="bibr" rid="B64">1995</xref>; Brazel et al., <xref ref-type="bibr" rid="B13">2005</xref>; Jansson et al., <xref ref-type="bibr" rid="B46">2011</xref>, <xref ref-type="bibr" rid="B45">2013</xref>; Achuta et al., <xref ref-type="bibr" rid="B1">2017</xref>). In the rat brain, GluA2-lacking AMPARs are expressed during the first postnatal week initially in radial glia (López et al., <xref ref-type="bibr" rid="B63">1994</xref>) followed by an “inside-out” gradient in pre-oligodendrocytes and subplate neurons and later in cortical neurons (Talos et al., <xref ref-type="bibr" rid="B98">2006</xref>). Oligodendrocyte progenitor cells (OPCs) express AMPA/kainate (KA) receptors and specific agonists of these receptors cause reversible G1 arrest of OPC cell cycle <italic>via</italic> Ca<sup>2+</sup>-independent means (Gallo et al., <xref ref-type="bibr" rid="B32">1996</xref>). Ca<sup>2+</sup> influx-mediated excitotoxic cell death is promoted by activation of AMPA/KA receptors in postmitotic pre-oligodendrocytes, whereas a similar sensitivity to excitotoxic insults is not observed in proliferating OPCs or mature myelinating oligodendrocytes.</p>
<p>When compared with normal controls at the early stage of progenitor differentiation, functional analysis has revealed enhanced intracellular Ca<sup>2+</sup> responses to AMPAR activation in neural progenitors differentiated from human induced pluripotent stem (iPS) cells generated from somatic cells of FXS males (Achuta et al., <xref ref-type="bibr" rid="B2">2018</xref>). Augmented CP-AMPAR responses associate with increased Ca<sup>2+</sup> influx <italic>via</italic> L-type voltage-gated calcium channels and hyperresponsiveness to membrane depolarization and to NMDA and mGluR type I receptor activation (Danesi et al., <xref ref-type="bibr" rid="B20">2018</xref>). Whitney et al. have shown that activation of CP-AMPARs induces neuronal differentiation in human neural progenitors. Consistent with these findings, differentiation of glutamate-responsive progenitors is enhanced from FXS progenitors (Whitney et al., <xref ref-type="bibr" rid="B106">2008</xref>). Blocking CP-AMPARs also affects neurite outgrowth in both FXS and wild-type neural progenitors (Whitney et al., <xref ref-type="bibr" rid="B106">2008</xref>; Achuta et al., <xref ref-type="bibr" rid="B2">2018</xref>). The increase in CP-AMPARs correlates with an increased inward rectification and a reduced number of GluA2 subunit-expressing cells in mouse FXS progenitors. CP-AMPARs provide an important route for Ca<sup>2+</sup> entry into progenitors, and changes of Ca<sup>2+</sup> signaling can contribute to altered fate determination, differentiation, and migration of FXS neural progenitors (Castrén et al., <xref ref-type="bibr" rid="B19">2005</xref>; Tervonen et al., <xref ref-type="bibr" rid="B100">2009</xref>; Saffary and Xie, <xref ref-type="bibr" rid="B85">2011</xref>; Sheridan et al., <xref ref-type="bibr" rid="B89">2011</xref>; Liu et al., <xref ref-type="bibr" rid="B62">2012</xref>; Doers et al., <xref ref-type="bibr" rid="B25">2014</xref>; Li and Zhao, <xref ref-type="bibr" rid="B59">2014</xref>; Telias et al., <xref ref-type="bibr" rid="B99">2015</xref>). Increased Ca<sup>2+</sup> influx through CP-AMPARs renders FXS neural progenitors more susceptible to excitotoxicity. Increased vulnerability may act as a selective factor during cell differentiation and may interfere with establishment of neocortical circuits leading to network hyperexcitability in the <italic>Fmr1</italic> KO mouse brain (Meredith et al., <xref ref-type="bibr" rid="B69">2007</xref>, <xref ref-type="bibr" rid="B68">2011</xref>). Since CP-AMPARs also influence morphological plasticity and migration of neurons, increased CP-AMPAR signaling may be involved in the delayed positioning of glutamatergic neurons to the cortical plate and abnormal morphological transformation of migrating cells in the developing cortex of the FXS mouse (La Fata et al., <xref ref-type="bibr" rid="B53">2014</xref>).</p>
<p>The GluA2 subunit imparts Ca<sup>2+</sup> -permeability to AMPARs only when it contains an arginine residue in a critical position (“Q/R site”) of the ion channel, which is introduced by RNA editing of the GluA2 primary transcript by adenosine deaminase ADAR2 (Sommer et al., <xref ref-type="bibr" rid="B93">1991</xref>; Wong et al., <xref ref-type="bibr" rid="B107">2001</xref>; Wright and Vissel, <xref ref-type="bibr" rid="B108">2012</xref>). The GluA2 transcripts are nearly entirely edited in the adult brain (Wright and Vissel, <xref ref-type="bibr" rid="B108">2012</xref>). During development, including in neural progenitors, editing of GluA2 transcripts is also very efficient, although ADAR2 expression levels are low (Pachernegg et al., <xref ref-type="bibr" rid="B73">2015</xref>). Unedited Ca<sup>2+</sup>-permeable AMPARs are found under pathological conditions (Kwak and Kawahara, <xref ref-type="bibr" rid="B52">2005</xref>; Peng et al., <xref ref-type="bibr" rid="B76">2006</xref>). The <italic>Drosophila</italic> fragile X homolog (dFMR1) modulates activity of the RNA editing enzyme dADAR (Bhogal et al., <xref ref-type="bibr" rid="B11">2011</xref>) and it was recently shown that FMRP promotes RNA editing in the human brain (Tran et al., <xref ref-type="bibr" rid="B101">2019</xref>). FMRP regulation of RNA editing was identified as a common mechanism causing hypoediting of GRIA2 and GRIA4 in the human ASD and FXS brain (Tran et al., <xref ref-type="bibr" rid="B101">2019</xref>).</p>
</sec>
<sec id="s5">
<title>miRNA-Dependent Regulation of AMPAR</title>
<p>Numerous mammalian genes are targets of miRNAs (Lewis et al., <xref ref-type="bibr" rid="B57">2005</xref>). These small (19–24 nucleotides in length) noncoding RNAs act as post-transcriptional regulators of mRNA translation and stability (Lee et al., <xref ref-type="bibr" rid="B56">1993</xref>; Bartel, <xref ref-type="bibr" rid="B4">2004</xref>). In the nervous system, miRNAs play important regulatory roles during synapse formation and in synaptic plasticity and memory formation (Fregeac et al., <xref ref-type="bibr" rid="B30">2016</xref>). Several miRNAs are implicated in the etiology and pathogenesis of neurodegenerative, neurological, and neuropsychiatric disorders, including autism (Beveridge et al., <xref ref-type="bibr" rid="B10">2010</xref>; Ghahramani Seno et al., <xref ref-type="bibr" rid="B88">2011</xref>). A number of miRNAs, including miR-124 (Ho et al., <xref ref-type="bibr" rid="B42">2014</xref>), miR-181 (Beveridge et al., <xref ref-type="bibr" rid="B10">2010</xref>), miR-223 (Harraza et al., <xref ref-type="bibr" rid="B39">2012</xref>), and miR-409 and miR-495 (Capauto et al., <xref ref-type="bibr" rid="B17">2018</xref>) have been found to target GluA2 AMPAR subunit mRNA and therefore have the potential to regulate subunit composition and calcium-permeability of AMPAR.</p>
<p>Reduced GluA2 protein expression correlates with increased expression of the noncoding<italic> MIR-181A1</italic> gene (the host gene of mature miRNAs) and mature <italic>miR-181a</italic> in FXS neural progenitors (Achuta et al., <xref ref-type="bibr" rid="B2">2018</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). Increased expression of <italic>miR-181a-5p</italic> and <italic>miR-181a-3p</italic> was found in both human and mouse neural progenitors at days 1 and 7 of neurosphere differentiation. Expression of <italic>miR-181b</italic> was not detectable at these early differentiation timepoints, which is consistent with the low expression of <italic>miR-181b</italic> in the embryonic brain compared to that in the adult cortex (Hutchison et al., <xref ref-type="bibr" rid="B44">2013</xref>). Neurospheres consist of mixed populations of neural progenitors and these studies did not elucidate <italic>miR-181a</italic> expression and its functional consequences in a cell type-specific manner.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic presentation of increased differentiation of neural progenitors expressing Ca<sup>2+</sup>-permeable (CP; alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor, AMPAR) from human Fragile X syndrome (FXS) induced pluripotent stem (iPS)-derived neurospheres compared with normal healthy controls. The miR-181a-mediated regulation of Ca<sup>2+</sup>-permeability of the AMPAR is visualized in a FXS progenitor by showing the increased expression of the <italic>MIR181A1</italic> gene. This leads to an increase in the expression of mature miR-181a, which by interacting with the <italic>GRIA2</italic> mRNA, can post-trascriptionally reduce the translation of the GluA2 subunit. The edited GluA2 subunit is required for Ca<sup>2+</sup>-impermeability of the AMPAR.</p>
</caption>
<graphic xlink:href="fnsyn-11-00002-g0001"></graphic>
</fig>
<p>The association of miR-181 species to the FXS gene family with neuropsychiatric phenotype/ASD (Stepniak et al., <xref ref-type="bibr" rid="B95">2015</xref>) and a microduplication of chromosome 1q32.1 in the region comprising the <italic>MIR-181A1</italic> gene in a patient case with developmental delay and autistic features (Olson et al., <xref ref-type="bibr" rid="B720">2012</xref>) support a role for miR-181 in FXS/ASD. Furthermore, expression of miR-181 is increased in lymphoblastoid cell lines of individuals with ASD (Ghahramani Seno et al., <xref ref-type="bibr" rid="B88">2011</xref>) and in the superior temporal gyrus and the dorsolateral prefrontal cortex of individuals with schizophrenia (Beveridge et al., <xref ref-type="bibr" rid="B10">2010</xref>). There is evidence that miR-181a is developmentally regulated and involved in cell-fate determination in the central nervous system (Hutchison et al., <xref ref-type="bibr" rid="B44">2013</xref>). The target genes of the miR-181 family are implicated in regulation of developmental mechanisms (Saba et al., <xref ref-type="bibr" rid="B84">2012</xref>), neurotrophin signaling, and axon guidance (Yang et al., <xref ref-type="bibr" rid="B111">2014</xref>), consistent with a role of miR-181 in the neuropathology of neurodevelopmental disorders. Since expression of miRNAs is spatiotemporally regulated, the expression of the miR-181 family and other miRNAs that regulate GluA2 remain to be studied in detail in the mouse and human developing and mature FXS/ASD brain.</p>
</sec>
<sec id="s6">
<title>Conclusions/Summary</title>
<p>Functional changes of AMPARs and increased Ca<sup>2+</sup> influx through AMPARs play an important role in the neurobiology of FXS. AMPAR-mediated alterations may serve as common pathological mechanisms in FXS and ASD. This is supported by studies showing RNA hypoediting of AMPAR subunits in the human FXS and ASD brain (Tran et al., <xref ref-type="bibr" rid="B101">2019</xref>) and alterations of AMPAR subunit expression and trafficking by genetic mutations that cause ASD (Mignogna et al., <xref ref-type="bibr" rid="B70">2015</xref>). The contribution of miRNA-mediated regulation of CP-AMPAR signaling remains to be further explored.</p>
<p>CP-AMPARs are implicated as critical mediators of neuronal death in epilepsy, ischemia, traumatic brain injury, and neurodegenerative disorders (Pellegrini-Giampietro et al., <xref ref-type="bibr" rid="B75">1992</xref>; Spaethling et al., <xref ref-type="bibr" rid="B94">2008</xref>; Szczurowska et al., <xref ref-type="bibr" rid="B97">2016</xref>; Whitehead et al., <xref ref-type="bibr" rid="B105">2017</xref>). This emphasizes the importance of CP-AMPAR-dependent mechanisms in pathological processes in the brain and as a potential target for therapeutic intervention. Human iPS cell-derived neuronal cells offer possibilities to perform further studies in a cell type-dependent manner in the actual disease model. Many rescue strategies that target excessive protein synthesis show beneficial effects on synaptic function and behavioral phenotype in the FXS mouse model (Richter et al., <xref ref-type="bibr" rid="B81">2015</xref>). However, appropriate pharmaceutical compounds have not shown sufficient efficacy in clinical trials, thus indicating need for new treatment strategies (Berry-Kravis et al., <xref ref-type="bibr" rid="B8">2011</xref>; Erickson et al., <xref ref-type="bibr" rid="B27">2017</xref>). Improved understanding of alterations of CP-AMPAR signaling and their relationship to the direct pathophysiological and manifold compensatory changes in FXS may provide new avenues for treatment and biomarker discovery in FXS.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>MC wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.</p>
</sec>
<sec id="s8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The research was supported by grants from the Finnish Brain Research Foundation, the Magnus Ehrnrooth Foundation, the Sakari and Orvokki Sohlberg Foundation, and the Academy of Finland.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achuta</surname><given-names>V.</given-names></name><name><surname>Grym</surname><given-names>H.</given-names></name><name><surname>Putkonen</surname><given-names>N.</given-names></name><name><surname>Louhivuori</surname><given-names>V.</given-names></name><name><surname>Kärkkäinen</surname><given-names>V.</given-names></name><name><surname>Koistinaho</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome</article-title>. <source/>Dev. Neurobiol.
<volume>77</volume>, <fpage>438</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22419</pub-id><pub-id pub-id-type="pmid">27411166</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achuta</surname><given-names>V.</given-names></name><name><surname>Möykkynen</surname><given-names>T.</given-names></name><name><surname>Peteri</surname><given-names>U.-K.</given-names></name><name><surname>Turconi</surname><given-names>G.</given-names></name><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Keinänen</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Functional changes of AMPA responses in human induced pluripotent stem cell-derived neural progenitors in autism spectrum disorder</article-title>. <source/>Sci. Signal.
<volume>11</volume>:<fpage>eaan8784</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.aan8784</pub-id><pub-id pub-id-type="pmid">29339535</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group> (<year>2013</year>). <source/>Diagnostic and Statistical Manual of Mental Disorders, 5th Edn. Text Rev., DSM-5.
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association (APA)</publisher-name>.</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function</article-title>. <source/>Cell
<volume>116</volume>, <fpage>281</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(04)00045-5</pub-id><pub-id pub-id-type="pmid">14744438</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassel</surname><given-names>G.</given-names></name><name><surname>Warren</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function</article-title>. <source/>Neuron
<volume>60</volume>, <fpage>201</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.004</pub-id><pub-id pub-id-type="pmid">18957214</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bear</surname><given-names>M.</given-names></name><name><surname>Huber</surname><given-names>K.</given-names></name><name><surname>Warren</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>The mGluR theory of fragile X mental retardation</article-title>. <source/>Trends Neurosci.
<volume>27</volume>, <fpage>370</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id><pub-id pub-id-type="pmid">15219735</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry-Kravis</surname><given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>Epilepsy in fragile X syndrome</article-title>. <source/>Dev. Med. Child Neurol.
<volume>44</volume>, <fpage>724</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1017/s0012162201002833</pub-id><pub-id pub-id-type="pmid">12418611</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry-Kravis</surname><given-names>E.</given-names></name><name><surname>Knox</surname><given-names>A.</given-names></name><name><surname>Hervey</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Targeted treatments for fragile X syndrome</article-title>. <source/>J. Neurodev. Disord.
<volume>3</volume>, <fpage>193</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1007/s11689-011-9074-7</pub-id><pub-id pub-id-type="pmid">21484200</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besag</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Epilepsy in patients with autism: links, risks and treatment challenges</article-title>. <source/>Neuropsychiatr. Dis. Treat.
<volume>14</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.2147/ndt.s120509</pub-id><pub-id pub-id-type="pmid">29296085</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beveridge</surname><given-names>N. J.</given-names></name><name><surname>Gardiner</surname><given-names>E.</given-names></name><name><surname>Carrol</surname><given-names>A. P.</given-names></name><name><surname>Tooney</surname><given-names>P. A.</given-names></name><name><surname>Cairns</surname><given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Schizophrenia is associated with an increase in cortical microRNA biogenesis</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>1176</fpage>–<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.84</pub-id><pub-id pub-id-type="pmid">19721432</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhogal</surname><given-names>B.</given-names></name><name><surname>Jepson</surname><given-names>J.</given-names></name><name><surname>Savva</surname><given-names>Y.</given-names></name><name><surname>Pepper</surname><given-names>A.</given-names></name><name><surname>Reenan</surname><given-names>R.</given-names></name><name><surname>Jongens</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Modulation of dADAR-dependent RNA editing by the <italic>Drosophila</italic> fragile X mental retardation protein</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>1517</fpage>–<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2950</pub-id><pub-id pub-id-type="pmid">22037499</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowie</surname><given-names>D.</given-names></name><name><surname>Lange</surname><given-names>G.</given-names></name><name><surname>Mayer</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Activity-dependent modulation of glutamate receptors by polyamines</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>8175</fpage>–<lpage>8185</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-20-08175.1998</pub-id><pub-id pub-id-type="pmid">9763464</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazel</surname><given-names>C. Y.</given-names></name><name><surname>Nuñez</surname><given-names>J. L.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Glutamate enhances survival and proliferation of neural progenitors derived from the subventricular zone</article-title>. <source/>Neuroscience
<volume>131</volume>, <fpage>55</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.10.038</pub-id><pub-id pub-id-type="pmid">15680691</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>W.</given-names></name><name><surname>Jenkins</surname><given-names>E.</given-names></name><name><surname>Cohen</surname><given-names>I. L.</given-names></name><name><surname>Fisch</surname><given-names>G.</given-names></name><name><surname>Wolf-Schein</surname><given-names>E.</given-names></name><name><surname>Gross</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1986</year>). <article-title>Fragile X and autism: a multicenter survey</article-title>. <source/>Am. J. Med. Genet.
<volume>23</volume>, <fpage>341</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320230126</pub-id><pub-id pub-id-type="pmid">3513570</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>V.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Ceman</surname><given-names>S.</given-names></name><name><surname>Darnell</surname><given-names>J.</given-names></name><name><surname>O’Donnell</surname><given-names>W.</given-names></name><name><surname>Tenenbaum</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome</article-title>. <source/>Cell
<volume>107</volume>, <fpage>477</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(01)00568-2</pub-id><pub-id pub-id-type="pmid">11719188</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Kronengold</surname><given-names>J.</given-names></name><name><surname>Gazula</surname><given-names>V.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Strumbos</surname><given-names>J.</given-names></name><name><surname>Sigworth</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>819</fpage>–<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2563</pub-id><pub-id pub-id-type="pmid">20512134</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capauto</surname><given-names>D.</given-names></name><name><surname>Colantoni</surname><given-names>A.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Santini</surname><given-names>T.</given-names></name><name><surname>Peruzzi</surname><given-names>G.</given-names></name><name><surname>Biscarini</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>A regulatory circuitry between Gria2, miR-409, and miR-495 is affected by ALS FUS mutation in ESC-derived motor neurons</article-title>. <source/>Mol. Neurobiol.
<volume>55</volume>, <fpage>7635</fpage>–<lpage>7651</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-0884-4</pub-id><pub-id pub-id-type="pmid">29430619</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castagnola</surname><given-names>S.</given-names></name><name><surname>Delhaye</surname><given-names>S.</given-names></name><name><surname>Folci</surname><given-names>A.</given-names></name><name><surname>Paquet</surname><given-names>A.</given-names></name><name><surname>Brau</surname><given-names>F.</given-names></name><name><surname>Duprat</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>New insights into the role of Ca<sub>v</sub>2 protein family in calcium flux Deregulation in <italic>Fmr1</italic>-KO neurons</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>:<fpage>342</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00342</pub-id><pub-id pub-id-type="pmid">30319351</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castrén</surname><given-names>M.</given-names></name><name><surname>Tervonen</surname><given-names>T.</given-names></name><name><surname>Karkkainen</surname><given-names>V.</given-names></name><name><surname>Heinonen</surname><given-names>S.</given-names></name><name><surname>Castrén</surname><given-names>E.</given-names></name><name><surname>Larsson</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Altered differentiation of neural stem cells in fragile X syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>17834</fpage>–<lpage>17839</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0508995102</pub-id><pub-id pub-id-type="pmid">16314562</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danesi</surname><given-names>D.</given-names></name><name><surname>Achuta</surname><given-names>V.</given-names></name><name><surname>Corcoran</surname><given-names>P.</given-names></name><name><surname>Peteri</surname><given-names>U.-K.</given-names></name><name><surname>Turconi</surname><given-names>G.</given-names></name><name><surname>Matsui</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Increased calcium influx through L-type calcium channels in human and mouse neural progenitors lacking fragile X mental retardation protein</article-title>. <source/>Stem Cell Reports
<volume>11</volume>, <fpage>1449</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2018.11.003</pub-id><pub-id pub-id-type="pmid">30503263</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J.</given-names></name><name><surname>Van Driesche</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Hung</surname><given-names>K. Y.</given-names></name><name><surname>Mele</surname><given-names>A.</given-names></name><name><surname>Fraser</surname><given-names>C. E.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism</article-title>. <source/>Cell
<volume>146</volume>, <fpage>247</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.06.013</pub-id><pub-id pub-id-type="pmid">21784246</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>P.</given-names></name><name><surname>Rotman</surname><given-names>Z.</given-names></name><name><surname>Blundon</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Cavalli</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels</article-title>. <source/>Neuron
<volume>77</volume>, <fpage>696</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.018</pub-id><pub-id pub-id-type="pmid">23439122</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>N.</given-names></name><name><surname>Casimiro</surname><given-names>T.</given-names></name><name><surname>Gruber</surname><given-names>S.</given-names></name><name><surname>Vanderklish</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Early postnatal plasticity in neocortex of <italic>Fmr1</italic> knockout mice</article-title>. <source/>J. Neurophysiol.
<volume>96</volume>, <fpage>1734</fpage>–<lpage>1745</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00221.2006</pub-id><pub-id pub-id-type="pmid">16823030</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiCicco-Bloom</surname><given-names>E.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L.</given-names></name><name><surname>Courchesne</surname><given-names>E.</given-names></name><name><surname>Dager</surname><given-names>S.</given-names></name><name><surname>Schmitz</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>The developmental neurobiology of autism spectrum disorder</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>6897</fpage>–<lpage>6906</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1712-06.2006</pub-id><pub-id pub-id-type="pmid">16807320</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doers</surname><given-names>M. E.</given-names></name><name><surname>Musser</surname><given-names>M. T.</given-names></name><name><surname>Nichol</surname><given-names>R.</given-names></name><name><surname>Berndt</surname><given-names>E. R.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Gomez</surname><given-names>T. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth</article-title>. <source/>Stem Cells Dev.
<volume>23</volume>, <fpage>1777</fpage>–<lpage>1787</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2014.0030</pub-id><pub-id pub-id-type="pmid">24654675</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donevan</surname><given-names>S.</given-names></name><name><surname>Rogawski</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Intracellular polyamines mediate inward rectification of Ca<sup>2+</sup>-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>92</volume>, <fpage>9298</fpage>–<lpage>9302</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.20.9298</pub-id><pub-id pub-id-type="pmid">7568121</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>C.</given-names></name><name><surname>Davenport</surname><given-names>M.</given-names></name><name><surname>Schaefer</surname><given-names>T.</given-names></name><name><surname>Wink</surname><given-names>L.</given-names></name><name><surname>Pedapati</surname><given-names>E.</given-names></name><name><surname>Sweeney</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Fragile X targeted pharmacotherapy: lessons learned and future directions</article-title>. <source/>J. Neurodev. Disord.
<volume>9</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/s11689-017-9186-9</pub-id><pub-id pub-id-type="pmid">28616096</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferron</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Fragile X mental retardation protein controls ion channel expression and activity</article-title>. <source/>J. Physiol.
<volume>594</volume>, <fpage>5861</fpage>–<lpage>5867</lpage>. <pub-id pub-id-type="doi">10.1113/jp270675</pub-id><pub-id pub-id-type="pmid">26864773</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fombonne</surname><given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Epidemiological surveys of autism and other pervasive developmental disorders: an update</article-title>. <source/>J. Autism Dev. Disord.
<volume>33</volume>, <fpage>365</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1023/A:1025054610557</pub-id><pub-id pub-id-type="pmid">12959416</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fregeac</surname><given-names>J.</given-names></name><name><surname>Colleaux</surname><given-names>L.</given-names></name><name><surname>Nguyen</surname><given-names>L. S.</given-names></name></person-group> (<year>2016</year>). <article-title>The emerging roles of MicroRNAs in autism spectrum disorders</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>71</volume>, <fpage>729</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.10.018</pub-id><pub-id pub-id-type="pmid">27793596</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>L.</given-names></name><name><surname>Hardan</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Developing medications targeting glutamatergic dysfunction in autism: progress to date</article-title>. <source/>CNS Drugs
<volume>29</volume>, <fpage>453</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1007/s40263-015-0252-0</pub-id><pub-id pub-id-type="pmid">26104862</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>V.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>McBain</surname><given-names>C.</given-names></name><name><surname>Wright</surname><given-names>P.</given-names></name><name><surname>Knutson</surname><given-names>P.</given-names></name><name><surname>Armstrong</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K<sup>+</sup> channel block</article-title>. <source/>J. Neurosci.
<volume>15</volume>, <fpage>2659</fpage>–<lpage>2670</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-08-02659.1996</pub-id><pub-id pub-id-type="pmid">8786442</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>J.</given-names></name><name><surname>Bartley</surname><given-names>A.</given-names></name><name><surname>Hays</surname><given-names>S.</given-names></name><name><surname>Huber</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome</article-title>. <source/>J. Neurophysiol.
<volume>100</volume>, <fpage>2615</fpage>–<lpage>2626</lpage>. <pub-id pub-id-type="doi">10.1152/jn.90752.2008</pub-id><pub-id pub-id-type="pmid">18784272</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonçalves</surname><given-names>J. T.</given-names></name><name><surname>Anstey</surname><given-names>J. E.</given-names></name><name><surname>Golshani</surname><given-names>P.</given-names></name><name><surname>Portera-Cailliau</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Circuit level defects in the developing neocortex of Fragile X mice</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>903</fpage>–<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3415</pub-id><pub-id pub-id-type="pmid">23727819</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Polich</surname><given-names>E.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Christopher</surname><given-names>D.</given-names></name><name><surname>Am</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Fragile X Proteins FMRP and FXR2P control synaptic GluA1 expression and neuronal maturation via distinct mechanisms</article-title>. <source/>Cell Rep.
<volume>11</volume>, <fpage>1651</fpage>–<lpage>1666</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.05.013</pub-id><pub-id pub-id-type="pmid">26051932</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R.</given-names></name><name><surname>Hoem</surname><given-names>G.</given-names></name><name><surname>Hagerman</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Fragile X and autism: intertwined at the molecular level leading to targeted treatments</article-title>. <source/>Mol. Autism
<volume>1</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-1-12</pub-id><pub-id pub-id-type="pmid">20678244</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanse</surname><given-names>E.</given-names></name><name><surname>Seth</surname><given-names>H.</given-names></name><name><surname>Riebe</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>AMPA-silent synapses in brain development and pathology</article-title>. <source/>Nat. Rev. Neurosci.
<volume>14</volume>, <fpage>839</fpage>–<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3642</pub-id><pub-id pub-id-type="pmid">24201185</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harlow</surname><given-names>E.</given-names></name><name><surname>Till</surname><given-names>S.</given-names></name><name><surname>Russell</surname><given-names>T.</given-names></name><name><surname>Wijetunge</surname><given-names>L.</given-names></name><name><surname>Kind</surname><given-names>P.</given-names></name><name><surname>Contractor</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Critical period plasticity is disrupted in the barrel cortex of <italic>FMR1</italic> knockout mice</article-title>. <source/>Neuron
<volume>65</volume>, <fpage>385</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.024</pub-id><pub-id pub-id-type="pmid">20159451</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harraza</surname><given-names>M.</given-names></name><name><surname>Eackera</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Dawson</surname><given-names>T.</given-names></name><name><surname>Dawson</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>). <article-title>MicroRNA-223 is neuroprotective by targeting glutamate receptors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>109</volume>, <fpage>18962</fpage>–<lpage>18967</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1121288109</pub-id><pub-id pub-id-type="pmid">23112146</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>R.</given-names></name><name><surname>Feinberg</surname><given-names>R.</given-names></name><name><surname>Vaurio</surname><given-names>R.</given-names></name><name><surname>Passanante</surname><given-names>N.</given-names></name><name><surname>Thompson</surname><given-names>R.</given-names></name><name><surname>Kaufmann</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation</article-title>. <source/>Am. J. Med. Genet.
<volume>149A</volume>, <fpage>1125</fpage>–<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.32848</pub-id><pub-id pub-id-type="pmid">19441123</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>S.</given-names></name><name><surname>Hotta</surname><given-names>K.</given-names></name><name><surname>Kubo</surname><given-names>Y.</given-names></name><name><surname>Nishino</surname><given-names>A.</given-names></name><name><surname>Okabe</surname><given-names>S.</given-names></name><name><surname>Okamura</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>AMPA glutamate receptors are required for sensory-organ formation and morphogenesis in the basal chordate</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>114</volume>, <fpage>3939</fpage>–<lpage>3944</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1612943114</pub-id><pub-id pub-id-type="pmid">28348228</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>V.</given-names></name><name><surname>Dallalzadeh</surname><given-names>L.</given-names></name><name><surname>Karathanasis</surname><given-names>N.</given-names></name><name><surname>Keles</surname><given-names>M.</given-names></name><name><surname>Vangala</surname><given-names>S.</given-names></name><name><surname>Grogan</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>GluA2 mRNA distribution and regulation by miR-124 in hippocampal neurons</article-title>. <source/>Mol. Cell. Neurosci.
<volume>61</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2014.04.006</pub-id><pub-id pub-id-type="pmid">24784359</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>K.</given-names></name><name><surname>Gallagher</surname><given-names>S.</given-names></name><name><surname>Warren</surname><given-names>S.</given-names></name><name><surname>Bear</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Altered synaptic plasticity in a mouse model of Fragile X mental retardation</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>99</volume>, <fpage>7746</fpage>–<lpage>7750</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.122205699</pub-id><pub-id pub-id-type="pmid">12032354</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchison</surname><given-names>E. R.</given-names></name><name><surname>Kawamoto</surname><given-names>E. M.</given-names></name><name><surname>Taub</surname><given-names>D. D.</given-names></name><name><surname>Lal</surname><given-names>A.</given-names></name><name><surname>Abdelmohsen</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes</article-title>. <source/>Glia
<volume>61</volume>, <fpage>1018</fpage>–<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22483</pub-id><pub-id pub-id-type="pmid">23650073</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansson</surname><given-names>L. C.</given-names></name><name><surname>Louhivuori</surname><given-names>L.</given-names></name><name><surname>Wigren</surname><given-names>H. K.</given-names></name><name><surname>Nordström</surname><given-names>T.</given-names></name><name><surname>Louhivuori</surname><given-names>V.</given-names></name><name><surname>Castrén</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Effect of glutamate receptor antagonists on migrating neural progenitor cells</article-title>. <source/>Eur. J. Neurosci.
<volume>37</volume>, <fpage>1369</fpage>–<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12152</pub-id><pub-id pub-id-type="pmid">23383979</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansson</surname><given-names>L. C.</given-names></name><name><surname>Wigren</surname><given-names>H. K.</given-names></name><name><surname>Nordström</surname><given-names>T.</given-names></name><name><surname>Akerman</surname><given-names>K. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Functional α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in differentiating embryonic neural progenitor cells</article-title>. <source/>Neuroreport
<volume>22</volume>, <fpage>282</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1097/wnr.0b013e3283457b34</pub-id><pub-id pub-id-type="pmid">21399551</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Warren</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>Understanding the molecular basis of fragile X syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>9</volume>, <fpage>901</fpage>–<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.6.901</pub-id><pub-id pub-id-type="pmid">10767313</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>W.</given-names></name><name><surname>Kidd</surname><given-names>S.</given-names></name><name><surname>Andrews</surname><given-names>H.</given-names></name><name><surname>Budimirovic</surname><given-names>D.</given-names></name><name><surname>Esler</surname><given-names>A.</given-names></name><name><surname>Haas-Givler</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment</article-title>. <source/>Pediatrics
<volume>139</volume>, <fpage>S194</fpage>–<lpage>S206</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2016-1159F</pub-id><pub-id pub-id-type="pmid">28814540</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Kang</surname><given-names>R.</given-names></name><name><surname>Gonzales</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism</article-title>. <source/>Neuropsychopharmacology
<volume>44</volume>, <fpage>314</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1038/s41386-018-0098-5</pub-id><pub-id pub-id-type="pmid">29899405</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kluger</surname><given-names>G.</given-names></name><name><surname>Böhm</surname><given-names>I.</given-names></name><name><surname>Laub</surname><given-names>M.</given-names></name><name><surname>Waldenmayer</surname><given-names>C.</given-names></name></person-group> (<year>1996</year>). <article-title>Epilepsy and fragile X gene mutations</article-title>. <source/>Pediatr. Neurol.
<volume>15</volume>, <fpage>358</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1016/s0887-8994(96)00251-2</pub-id><pub-id pub-id-type="pmid">8972540</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S. S.</given-names></name><name><surname>Bacci</surname><given-names>A.</given-names></name><name><surname>Kharazia</surname><given-names>V.</given-names></name><name><surname>Huguenard</surname><given-names>J. R.</given-names></name></person-group> (<year>2002</year>). <article-title>A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons</article-title>. <source/>J. Neurosci.
<volume>22</volume>, <fpage>3005</fpage>–<lpage>3015</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-08-03005.2002</pub-id><pub-id pub-id-type="pmid">11943803</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>S.</given-names></name><name><surname>Kawahara</surname><given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis</article-title>. <source/>J. Mol. Med.
<volume>83</volume>, <fpage>110</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-004-0599-z</pub-id><pub-id pub-id-type="pmid">15624111</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Fata</surname><given-names>G.</given-names></name><name><surname>Gärtner</surname><given-names>A.</given-names></name><name><surname>Domínguez-Iturza</surname><given-names>N.</given-names></name><name><surname>Dresselaers</surname><given-names>T.</given-names></name><name><surname>Dawitz</surname><given-names>J.</given-names></name><name><surname>Poorthuis</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>1693</fpage>–<lpage>1700</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3870</pub-id><pub-id pub-id-type="pmid">25402856</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalanne</surname><given-names>T.</given-names></name><name><surname>Oyrer</surname><given-names>J.</given-names></name><name><surname>Mancino</surname><given-names>A.</given-names></name><name><surname>Gregor</surname><given-names>E.</given-names></name><name><surname>Chung</surname><given-names>A.</given-names></name><name><surname>Huynh</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Synapse-specific expression of calcium-permeable AMPA receptors in neocortical layer 5</article-title>. <source/>J. Physiol.
<volume>594</volume>, <fpage>837</fpage>–<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1113/jp271394</pub-id><pub-id pub-id-type="pmid">26537662</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauterborn</surname><given-names>J.</given-names></name><name><surname>Rex</surname><given-names>C.</given-names></name><name><surname>Kramár</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Pandyarajan</surname><given-names>V.</given-names></name><name><surname>Lynch</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>10685</fpage>–<lpage>10694</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2624-07.2007</pub-id><pub-id pub-id-type="pmid">17913902</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>R.</given-names></name><name><surname>Feinbaum</surname><given-names>R.</given-names></name><name><surname>Ambros</surname><given-names>V.</given-names></name></person-group> (<year>1993</year>). <article-title>The <italic>C. elegans</italic> heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14</article-title>. <source/>Cell
<volume>75</volume>, <fpage>843</fpage>–<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90529-y</pub-id><pub-id pub-id-type="pmid">8252621</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>B. P.</given-names></name><name><surname>Burge</surname><given-names>C. B.</given-names></name><name><surname>Bartel</surname><given-names>D. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>. <source/>Cell
<volume>120</volume>, <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.12.035</pub-id><pub-id pub-id-type="pmid">15652477</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Pelletier</surname><given-names>M.</given-names></name><name><surname>Perez Velazquez</surname><given-names>J.</given-names></name><name><surname>Carlen</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency</article-title>. <source/>Mol. Cell. Neurosci.
<volume>19</volume>, <fpage>138</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1006/mcne.2001.1085</pub-id><pub-id pub-id-type="pmid">11860268</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>Concise review: fragile X proteins in stem cell maintenance and differentiation</article-title>. <source/>Stem Cells
<volume>32</volume>, <fpage>1724</fpage>–<lpage>1733</lpage>. <pub-id pub-id-type="doi">10.1002/stem.1698</pub-id><pub-id pub-id-type="pmid">24648324</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lidow</surname><given-names>M.</given-names></name><name><surname>Rakic</surname><given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>Neurotransmitter receptors in the proliferative zones of the developing primate occipital lobe</article-title>. <source/>J. Comp. Neurol.
<volume>360</volume>, <fpage>393</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903600303</pub-id><pub-id pub-id-type="pmid">8543647</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lintas</surname><given-names>C.</given-names></name><name><surname>Sacco</surname><given-names>R.</given-names></name><name><surname>Persico</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Genome-wide expression studies in autism spectrum disorder, Rett syndrome and Down syndrome</article-title>. <source/>Neurobiol. Dis.
<volume>45</volume>, <fpage>57</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.11.010</pub-id><pub-id pub-id-type="pmid">21130877</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Koscielska</surname><given-names>K. A.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Hulsizer</surname><given-names>S.</given-names></name><name><surname>Grace</surname><given-names>N.</given-names></name><name><surname>Mitchell</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Signaling defects in iPSC-derived fragile X premutation neurons</article-title>. <source/>Hum. Mol. Genet.
<volume>21</volume>, <fpage>3795</fpage>–<lpage>3805</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds207</pub-id><pub-id pub-id-type="pmid">22641815</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López</surname><given-names>T.</given-names></name><name><surname>López-Colomé</surname><given-names>A.</given-names></name><name><surname>Ortega</surname><given-names>A.</given-names></name></person-group> (<year>1994</year>). <article-title>AMPA/KA receptor expression in radial glia</article-title>. <source/>Neuroreport
<volume>12</volume>, <fpage>504</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199401120-00034</pub-id><pub-id pub-id-type="pmid">8003684</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LoTurco</surname><given-names>J.</given-names></name><name><surname>Owens</surname><given-names>D.</given-names></name><name><surname>Heath</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>M.</given-names></name><name><surname>Kriegstein</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis</article-title>. <source/>Neuron
<volume>15</volume>, <fpage>1287</fpage>–<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90008-x</pub-id><pub-id pub-id-type="pmid">8845153</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louhivuori</surname><given-names>V.</given-names></name><name><surname>Arvio</surname><given-names>M.</given-names></name><name><surname>Soronen</surname><given-names>P.</given-names></name><name><surname>Oksanen</surname><given-names>V.</given-names></name><name><surname>Paunio</surname><given-names>T.</given-names></name><name><surname>Castren</surname><given-names>M. L.</given-names></name></person-group> (<year>2009</year>). <article-title>The Val66Met polymorphism in the BDNF gene is associated with epilepsy in fragile X syndrome</article-title>. <source/>Epilepsy Res.
<volume>85</volume>, <fpage>114</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2009.01.005</pub-id><pub-id pub-id-type="pmid">19394799</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malenka</surname><given-names>R.</given-names></name><name><surname>Nicoll</surname><given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Silent synapses speak up</article-title>. <source/>Neuron
<volume>19</volume>, <fpage>473</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80362-1</pub-id><pub-id pub-id-type="pmid">9331339</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meredith</surname><given-names>R.</given-names></name><name><surname>Mansvelder</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>STDP and mental retardation: dysregulation of dendritic excitability in fragile X syndrome</article-title>. <source/>Front. Synaptic Neurosci.
<volume>2</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2010.00010</pub-id><pub-id pub-id-type="pmid">21423496</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meredith</surname><given-names>R.</given-names></name><name><surname>de Jong</surname><given-names>R.</given-names></name><name><surname>Mansvelder</surname><given-names>H. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse</article-title>. <source/>Neurobiol. Dis.
<volume>41</volume>, <fpage>104</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.08.026</pub-id><pub-id pub-id-type="pmid">20817093</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meredith</surname><given-names>R.</given-names></name><name><surname>Holmgren</surname><given-names>C.</given-names></name><name><surname>Weidum</surname><given-names>M.</given-names></name><name><surname>Burnashev</surname><given-names>N.</given-names></name><name><surname>Huibert</surname><given-names>D.</given-names></name><name><surname>Mansvelder</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1</article-title>. <source/>Neuron
<volume>54</volume>, <fpage>627</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.04.028</pub-id><pub-id pub-id-type="pmid">17521574</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mignogna</surname><given-names>M.</given-names></name><name><surname>Giannandrea</surname><given-names>M.</given-names></name><name><surname>Gurgone</surname><given-names>A.</given-names></name><name><surname>Fanelli</surname><given-names>F.</given-names></name><name><surname>Raimondi</surname><given-names>F.</given-names></name><name><surname>Mapelli</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition</article-title>. <source/>Nat. Comun.
<volume>6</volume>:<fpage>6504</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms7504</pub-id><pub-id pub-id-type="pmid">25784538</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamoto</surname><given-names>M.</given-names></name><name><surname>Nalavadi</surname><given-names>V.</given-names></name><name><surname>Epstein</surname><given-names>M.</given-names></name><name><surname>Narayanan</surname><given-names>U.</given-names></name><name><surname>Bassell</surname><given-names>G.</given-names></name><name><surname>Warren</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>104</volume>, <fpage>15537</fpage>–<lpage>15542</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707484104</pub-id><pub-id pub-id-type="pmid">17881561</pub-id></mixed-citation>
</ref>
<ref id="B720">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>H. E.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Poduri</surname><given-names>A.</given-names></name><name><surname>Gorman</surname><given-names>M.</given-names></name><name><surname>Dies</surname><given-names>K. A.</given-names></name><name><surname>Robbins</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Micro-duplications of 1q32.1 associated with neurodevelopmental delay</article-title>. <source/>Eur. J. Med. Genetics.
<volume>55</volume>, <fpage>145</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2011.12.008</pub-id><pub-id pub-id-type="pmid">22266072</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of <italic>de novo</italic> mutations</article-title>. <source/>Nature
<volume>485</volume>, <fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id><pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pachernegg</surname><given-names>S.</given-names></name><name><surname>Münster</surname><given-names>Y.</given-names></name><name><surname>Muth-Köhne</surname><given-names>E.</given-names></name><name><surname>Fuhrmann</surname><given-names>G.</given-names></name><name><surname>Hollmann</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>GluA2 is rapidly edited at the Q/R site during neural differentiation <italic>in vitro</italic></article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>69</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00069</pub-id><pub-id pub-id-type="pmid">25798088</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>C.</given-names></name><name><surname>Eberhart</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>The neurobiology of autism</article-title>. <source/>Brain Pathol.
<volume>17</volume>, <fpage>434</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2007.00102.x</pub-id><pub-id pub-id-type="pmid">17919129</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini-Giampietro</surname><given-names>D. E.</given-names></name><name><surname>Zukin</surname><given-names>R. S.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Cho</surname><given-names>S.</given-names></name><name><surname>Pulsinelli</surname><given-names>W. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>89</volume>, <fpage>10499</fpage>–<lpage>10503</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.21.10499</pub-id><pub-id pub-id-type="pmid">1438239</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>P.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Tu</surname><given-names>W.</given-names></name><name><surname>Soundarapandian</surname><given-names>M.</given-names></name><name><surname>Molner</surname><given-names>P.</given-names></name><name><surname>Zhu</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia</article-title>. <source/>Neuron
<volume>49</volume>, <fpage>719</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.01.025</pub-id><pub-id pub-id-type="pmid">16504947</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persico</surname><given-names>A.</given-names></name><name><surname>Napolioni</surname><given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Autism genetics</article-title>. <source/>Behav. Brain Res.
<volume>251</volume>, <fpage>95</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2013.06.012</pub-id><pub-id pub-id-type="pmid">23769996</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Pagnamenta</surname><given-names>A.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Anney</surname><given-names>R.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Regan</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>. <source/>Nature
<volume>466</volume>, <fpage>368</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nature09146</pub-id><pub-id pub-id-type="pmid">20531469</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>A.</given-names></name><name><surname>Jeon</surname><given-names>O.</given-names></name><name><surname>Zimmerman</surname><given-names>A.</given-names></name><name><surname>Blue</surname><given-names>M. E.</given-names></name><name><surname>Pevsner</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Postmortem brain abnormalities of the glutamate neurotrasmitter system in autism</article-title>. <source/>Neurology
<volume>57</volume>, <fpage>1618</fpage>–<lpage>1628</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.57.9.1618</pub-id><pub-id pub-id-type="pmid">11706102</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname><given-names>S.</given-names></name><name><surname>Woodroffe</surname><given-names>A.</given-names></name><name><surname>Flodman</surname><given-names>P. L.</given-names></name><name><surname>Mays</surname><given-names>L. Z.</given-names></name><name><surname>Hanouni</surname><given-names>M.</given-names></name><name><surname>Modahl</surname><given-names>C. B.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter sub-units (AMPA 2, GLRA 3, GLRB) and neuropeptide receptors NPY1R, NPY5R</article-title>. <source/>BMC Med. Genet.
<volume>5</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2350-5-10</pub-id><pub-id pub-id-type="pmid">15090072</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>J. D.</given-names></name><name><surname>Bassell</surname><given-names>G. J.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Dysregulation and restoration of translational homeostasis in fragile X syndrome</article-title>. <source/>Nat. Rev. Neurosci.
<volume>16</volume>, <fpage>595</fpage>–<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1038/nrn4001</pub-id><pub-id pub-id-type="pmid">26350240</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffolo</surname><given-names>D.</given-names></name><name><surname>Iyer</surname><given-names>A.</given-names></name><name><surname>Cifelli</surname><given-names>P.</given-names></name><name><surname>Rosetti</surname><given-names>C.</given-names></name><name><surname>Muhlebner</surname><given-names>A.</given-names></name><name><surname>Van Scheppingen</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions</article-title>. <source/>Neurobiol. Dis.
<volume>95</volume>, <fpage>93</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.07.014</pub-id><pub-id pub-id-type="pmid">27425893</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydzewska</surname><given-names>E.</given-names></name><name><surname>Hughes-Mccormack</surname><given-names>L.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Henderson</surname><given-names>A.</given-names></name><name><surname>Macintyre</surname><given-names>C.</given-names></name><name><surname>Rintoul</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Prevalence of sensory impairments, physical and intellectual disabilities, and mental health in children and young people with self/proxy-reported autism: observational study of a whole country population</article-title>. <source/>Autism [Epub ahead of print]. <pub-id pub-id-type="doi">10.1177/1362361318791279</pub-id><pub-id pub-id-type="pmid">30328695</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saba</surname><given-names>R.</given-names></name><name><surname>Störchel</surname><given-names>P.</given-names></name><name><surname>Aksoy-Aksel</surname><given-names>A.</given-names></name><name><surname>Kepura</surname><given-names>F.</given-names></name><name><surname>Lippi</surname><given-names>G.</given-names></name><name><surname>Plant</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons</article-title>. <source/>Mol. Cell. Biol.
<volume>32</volume>, <fpage>619</fpage>–<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.05896-11</pub-id><pub-id pub-id-type="pmid">22144581</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saffary</surname><given-names>R.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name></person-group> (<year>2011</year>). <article-title>FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>1427</fpage>–<lpage>1439</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4854-10.2011</pub-id><pub-id pub-id-type="pmid">21273427</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>M.</given-names></name><name><surname>Bray</surname><given-names>S. M.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanisms of fragile X syndrome: a twenty-year perspective</article-title>. <source/>Annu. Rev. Pathol.
<volume>7</volume>, <fpage>219</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132457</pub-id><pub-id pub-id-type="pmid">22017584</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlett</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Glutamate as a modulator of embryonic and adult neurogenesis</article-title>. <source/>Curr. Top. Med. Chem.
<volume>6</volume>, <fpage>949</fpage>–<lpage>960</lpage>. <pub-id pub-id-type="doi">10.2174/156802606777323665</pub-id><pub-id pub-id-type="pmid">16787269</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghahramani Seno</surname><given-names>M. M.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Gwadry</surname><given-names>F. G.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Casallo</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Gene and miRNA expression profiles in autism spectrum disorders</article-title>. <source/>Brain Res.
<volume>1380</volume>, <fpage>85</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.046</pub-id><pub-id pub-id-type="pmid">20868653</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>S. D.</given-names></name><name><surname>Theriault</surname><given-names>K. M.</given-names></name><name><surname>Reis</surname><given-names>S. A.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Madison</surname><given-names>J. M.</given-names></name><name><surname>Daheron</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Epigenetic characterization of the <italic>FMR1</italic> gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome</article-title>. <source/>PLoS One
<volume>6</volume>:<fpage>e26203</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0026203</pub-id><pub-id pub-id-type="pmid">22022567</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siew</surname><given-names>W.</given-names></name><name><surname>Tan</surname><given-names>K.</given-names></name><name><surname>Babaei</surname><given-names>M.</given-names></name><name><surname>Cheah</surname><given-names>P.</given-names></name><name><surname>Ling</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID and Fragile X syndrome</article-title>. <source/>Front. Cell. Neurosci.
<volume>7</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00041</pub-id><pub-id pub-id-type="pmid">23596395</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonoff</surname><given-names>E.</given-names></name><name><surname>Pickles</surname><given-names>A.</given-names></name><name><surname>Charman</surname><given-names>T.</given-names></name><name><surname>Chandler</surname><given-names>S.</given-names></name><name><surname>Loucas</surname><given-names>T.</given-names></name><name><surname>Baird</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>47</volume>, <fpage>921</fpage>–<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1097/chi.0b013e318179964f</pub-id><pub-id pub-id-type="pmid">18645422</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soden</surname><given-names>M. E.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>16910</fpage>–<lpage>16921</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3660-10.2010</pub-id><pub-id pub-id-type="pmid">21159962</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>B.</given-names></name><name><surname>Köhler</surname><given-names>M.</given-names></name><name><surname>Sprengel</surname><given-names>R.</given-names></name><name><surname>Seeburg</surname><given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>RNA editing in brain controls a determinant of ion flow in glutamate-gated channels</article-title>. <source/>Cell
<volume>67</volume>, <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90568-j</pub-id><pub-id pub-id-type="pmid">1717158</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaethling</surname><given-names>J. M.</given-names></name><name><surname>Klein</surname><given-names>D. M.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Meaney</surname><given-names>D. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate</article-title>. <source/>J. Neurotrauma
<volume>25</volume>, <fpage>1207</fpage>–<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2008.0532</pub-id><pub-id pub-id-type="pmid">18986222</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepniak</surname><given-names>B.</given-names></name><name><surname>Kästner</surname><given-names>A.</given-names></name><name><surname>Poggi</surname><given-names>G.</given-names></name><name><surname>Mitjans</surname><given-names>M.</given-names></name><name><surname>Begemann</surname><given-names>M.</given-names></name><name><surname>Hartmann</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes</article-title>. <source/>EMBO Mol. Med.
<volume>7</volume>, <fpage>1565</fpage>–<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201505696</pub-id><pub-id pub-id-type="pmid">26612855</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suvrathan</surname><given-names>A.</given-names></name><name><surname>Hoeffer</surname><given-names>C.</given-names></name><name><surname>Wong</surname><given-names>H.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name><name><surname>Chattarji</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>107</volume>, <fpage>11591</fpage>–<lpage>11596</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1002262107</pub-id><pub-id pub-id-type="pmid">20534533</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczurowska</surname><given-names>E.</given-names></name><name><surname>Ergang</surname><given-names>P.</given-names></name><name><surname>Kubova</surname><given-names>H.</given-names></name><name><surname>Druga</surname><given-names>R.</given-names></name><name><surname>Salaj</surname><given-names>M.</given-names></name><name><surname>Mares</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Influence of early life status epilepticus on the developmental expression profile of the GluA2 subunit of AMPA receptors</article-title>. <source/>Exp. Neurol.
<volume>283</volume>, <fpage>97</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.05.039</pub-id><pub-id pub-id-type="pmid">27288240</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talos</surname><given-names>D.</given-names></name><name><surname>Fishman</surname><given-names>R.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Folkerth</surname><given-names>R.</given-names></name><name><surname>Follett</surname><given-names>P.</given-names></name><name><surname>Volpe</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Developmental regulation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex</article-title>. <source/>J. Comp. Neurol.
<volume>497</volume>, <fpage>42</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/cne.20972</pub-id><pub-id pub-id-type="pmid">16680782</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telias</surname><given-names>M.</given-names></name><name><surname>Kuznitsov-Yanovsky</surname><given-names>L.</given-names></name><name><surname>Segal</surname><given-names>M.</given-names></name><name><surname>Ben-Yosef</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Functional deficiencies in fragile X neurons derived from human embryonic stem cells</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>15295</fpage>–<lpage>15306</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0317-15.2015</pub-id><pub-id pub-id-type="pmid">26586818</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tervonen</surname><given-names>T. A.</given-names></name><name><surname>Louhivuori</surname><given-names>V.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Hokkanen</surname><given-names>M. E.</given-names></name><name><surname>Kratochwil</surname><given-names>C. F.</given-names></name><name><surname>Zebryk</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome</article-title>. <source/>Neurobiol. Dis.
<volume>33</volume>, <fpage>250</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.10.010</pub-id><pub-id pub-id-type="pmid">19056494</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>S.</given-names></name><name><surname>Jun</surname><given-names>H.</given-names></name><name><surname>Bahn</surname><given-names>J.</given-names></name><name><surname>Azghadi</surname><given-names>A.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Van Nostrand</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Widespread RNA editing dysregulation in brains from autistic individuals</article-title>. <source/>Nat. Neurosci.
<volume>22</volume>, <fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0287-x</pub-id><pub-id pub-id-type="pmid">30559470</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzunova</surname><given-names>G.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Shepherd</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome</article-title>. <source/>Curr. Neuropharmacol.
<volume>12</volume>, <fpage>71</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.2174/1570159x113116660046</pub-id><pub-id pub-id-type="pmid">24533017</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Zhuo</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent α-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>, <fpage>21888</fpage>–<lpage>21901</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m110.116293</pub-id><pub-id pub-id-type="pmid">20457613</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A.</given-names></name><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Sutcliffe</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>Y.-H.</given-names></name><name><surname>Kuhl</surname><given-names>D. P.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibing length variation in fragile X syndrome</article-title>. <source/>Cell
<volume>65</volume>, <fpage>905</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-h</pub-id><pub-id pub-id-type="pmid">1710175</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname><given-names>G.</given-names></name><name><surname>Regan</surname><given-names>P.</given-names></name><name><surname>Whitcomb</surname><given-names>D. J.</given-names></name><name><surname>Cho</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Ca<sup>2+</sup>-permeable AMPA receptor: a new perspective on amyloid-β mediated pathophysiology of Alzheimer’s disease</article-title>. <source/>Neuropharmacology
<volume>112</volume>, <fpage>221</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.08.022</pub-id><pub-id pub-id-type="pmid">27561971</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitney</surname><given-names>N. P.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Erdmann</surname><given-names>N. B.</given-names></name><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Monaghan</surname><given-names>D. T.</given-names></name><name><surname>Zheng</surname><given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons</article-title>. <source/>FASEB J.
<volume>22</volume>, <fpage>2888</fpage>–<lpage>2900</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-104661</pub-id><pub-id pub-id-type="pmid">18403631</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. K.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Lazinski</surname><given-names>D. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Substrate recognition by ADAR1 and ADAR2</article-title>. <source/>RNA
<volume>7</volume>, <fpage>846</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1017/s135583820101007x</pub-id><pub-id pub-id-type="pmid">11421361</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>A.</given-names></name><name><surname>Vissel</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain</article-title>. <source/>Front. Mol. Neurosci.
<volume>5</volume>:<fpage>34</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2012.00034</pub-id><pub-id pub-id-type="pmid">22514516</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Malinow</surname><given-names>R.</given-names></name><name><surname>Cline</surname><given-names>H. T.</given-names></name></person-group> (<year>1996</year>). <article-title>Maturation of a central glutamatergic synapse</article-title>. <source/>Science
<volume>274</volume>, <fpage>972</fpage>–<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1126/science.274.5289.972</pub-id><pub-id pub-id-type="pmid">8875937</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndrome</article-title>. <source/>PLoS One
<volume>7</volume>:<fpage>e48741</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0048741</pub-id><pub-id pub-id-type="pmid">23119095</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Wan</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Evolution of the miR-181 microRNA family</article-title>. <source/>Comput. Biol. Med.
<volume>52</volume>, <fpage>82</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2014.06.004</pub-id><pub-id pub-id-type="pmid">25016292</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Bonnan</surname><given-names>A.</given-names></name><name><surname>Bony</surname><given-names>G.</given-names></name><name><surname>Ferezou</surname><given-names>I.</given-names></name><name><surname>Pietropaolo</surname><given-names>S.</given-names></name><name><surname>Ginger</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-/y) mice</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>1701</fpage>–<lpage>1709</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3864</pub-id><pub-id pub-id-type="pmid">25383903</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M. G.</given-names></name><name><surname>Toyoda</surname><given-names>H.</given-names></name><name><surname>Ko</surname><given-names>S. W.</given-names></name><name><surname>Ding</surname><given-names>H. K.</given-names></name><name><surname>Wu</surname><given-names>L. J.</given-names></name><name><surname>Zhuo</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Deficits in Trace Fear Memory and long-term potentiation in a mouse model for fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>7385</fpage>–<lpage>7392</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1520-05.2005</pub-id><pub-id pub-id-type="pmid">16093389</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zonouzi</surname><given-names>M.</given-names></name><name><surname>Renzi</surname><given-names>M.</given-names></name><name><surname>Farrant</surname><given-names>M.</given-names></name><name><surname>Cull-Candy</surname><given-names>S. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>1430</fpage>–<lpage>1438</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2942</pub-id><pub-id pub-id-type="pmid">21983683</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>